About GenXys
GenXys is a company based in Vancouver (Canada) founded in 2014 by Martin Dawes. GenXys has raised $1.33 million across 2 funding rounds from investors including GreenShield, TYDO INCUBATOR and TELUS Ventures. GenXys offers products and services including LabGx, CDSS, and OptimizeGx. GenXys operates in a competitive market with competitors including Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn, among others.
- Headquarter Vancouver, Canada
- Founders Martin Dawes
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.33 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
GreenShield
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenXys
GenXys offers a comprehensive portfolio of products and services, including LabGx, CDSS, and OptimizeGx.
Integrates genomic data for clinical decision-making in prescribing.
Delivers personalized treatment recommendations based on patient profiles.
Streamlines authorization processes for specialty medications.
People of GenXys
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of GenXys
GenXys has successfully raised a total of $1.33M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenXys
GenXys has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GreenShield, TYDO INCUBATOR and TELUS Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments in multiple sectors are directed by TELUS Ventures.
|
Locked | Locked | Locked | |
|
GreenShield is recognized for providing integrated health coverage and care.
|
Locked | Locked | Locked |
Investor details for GenXys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenXys
Investment portfolio details for GenXys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenXys
Detailed financials for GenXys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genxys Comparisons
Peer comparison for GenXys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenXys
GenXys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
Health management platform is provided for employers and insurers.
|
|
| Locked | Locked | Locked |
Personalized supplements are developed using blood and genetic tests.
|
|
| Locked | Locked | Locked |
Provider of genetic test for pain management
|
|
| Locked | Locked | Locked |
Provider of solutions to patients and their healthcare practitioners by providing insight into how they respond to specific medications based on their genetic profile
|
Detailed competitors of GenXys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genxys
Complete news archive for GenXys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenXys
GenXys was founded in 2014 and raised its 1st funding round 5 years after it was founded.
GenXys is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Martin Dawes is the current CEO of GenXys. They have also founded this company.
GenXys is a funded company, having raised a total of $1.33M across 2 funding rounds to date.
GenXys was founded in 2014 in Vancouver, Canada, within the healthcare sector focused on pharmacogenetics. Services include TreatGxPlus, a home collection kit ordered by consumers for genetic variant analysis affecting medication responses, with reports shared for professional consultations. TreatGx, a decision support tool, is offered to healthcare providers, integrating pharmacogenetic data, medical history, and clinical evidence to suggest tailored medication options. Operations emphasize evidence-based personalization across North America.
GenXys's top competitors include Newtopia, Invitae and VitaminLab.
GenXys offers LabGx, CDSS, and OptimizeGx.
GenXys has 3 investors. Key investors include GreenShield, TYDO INCUBATOR, and TELUS Ventures.